Gilead fights back against BMS Supreme Court pe­ti­tion in patent fight

A cou­ple months af­ter Bris­tol My­ers Squibb brought its patent fight with Gilead’s Kite unit to the Supreme Court, Gilead is now mak­ing the ar­gu­ment that the pe­ti­tion should be de­nied be­cause it chal­lenges more than 50 years of prece­dent.

Juno – which was ac­quired by Cel­gene and then Bris­tol My­ers Squibb — sued Gilead’s Kite unit back in 2017, al­leg­ing that the com­pa­ny’s CAR-T ther­a­py Yescar­ta in­fringed on patents that were li­censed to Juno by Memo­r­i­al Sloan Ket­ter­ing Can­cer Cen­ter.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.